SSG Capital Advisors (“SSG”) served as the investment banker to Axiom Real-Time Metrics Inc. (“Axiom” or the “Company”) in the sale of substantially all assets to Sitero Canada Inc. (“Sitero”). The sale was effectuated through a Court-supervised Receivership Proceeding in the Ontario Superior Court of Justice. The transaction closed in July 2025.

Founded in 2001 and headquartered in the Canadian province of Ontario, Axiom has delivered powerful, cost-effective eClinical solutions to small and medium-sized life science companies worldwide. Axiom’s Fusion eClinical Suite, a unified platform with 15+ integrated modules, including EDC, RTSM, CTMS, ePRO, eTMF, and more, serves as the central hub for clinical trial operations. Alongside its technology, Axiom provides full-service clinical support, including data management, biostatistics, pharmacovigilance, and regulatory compliance. Despite a strong operating history and differentiated service offering, Axiom faced macroeconomic pressures, including a decline in new clinical trials across the life sciences sector. In response, the Company implemented several initiatives to streamline operations and preserve liquidity in the face of a changing operating environment. 

In late 2024, SSG was engaged to advise Axiom through this period of strategic and financial transition. SSG worked closely with management and stakeholders to pursue a range of options, including potential sale and financing solutions. As market conditions evolved and liquidity pressures intensified, SSG executed a highly expedited sale process under a Canadian Receivership framework. Leveraging its deep expertise in life sciences, technology, and special situations, SSG generated significant market engagement and secured multiple indications of interest for the Company. The transaction with Sitero preserves Axiom’s technology platform, ensures continuity for its client base, and maximizes value for stakeholders. The outcome reflects SSG’s ability to deliver cross-border strategic solutions under complex and time-sensitive circumstances.

Sitero is a global clinical research partner with clinical, regulatory and safety service lines supporting life sciences and institutional research organizations in bringing treatments to market.

Other professionals who worked on the transaction include:

• Bobby Kofman, Jason Knight and Tony Trifunovic of KSV Restructuring Inc., financial advisor to Axiom’s senior secured creditor and Receiver of the assets, undertakings and properties of Axiom Real-Time Metrics Inc.;
• Jeffrey Levine and Waël Rostom of McMillan LLP, counsel to Axiom Real-Time Metrics Inc.; 
• Jennifer Stam, Lauren Archibald and Sophie Webb of Norton Rose Fulbright Canada LLP, counsel to Axiom’s senior secured creditor;
• George Benchetrit and David Im of Chaitons LLP, counsel to KSV Restructuring Inc.; and
• Stuart Brotman of Fasken Martineau DuMoulin LLP, counsel to Sitero Canada Inc.